Clinical Trials Browser

Temporarily not available × INDUSTRY × Expanded_access × Clear all

Carcinoma, Non-Small-Cell Lung

NCT07346105 2026-01-16

Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07319910 2026-01-06

PANOVA-3CA

Temporarily not available

Gastrointestinal

Locally Advanced Pancreatic Adenocarcinoma

NCT03842865 2025-06-05

Expanded Access of Vigil in Solid Tumors

Temporarily not available

GynecologicSarcoma

Uterine Cervical Neoplasms, Ovarian Neoplasms, Sarcoma, Ewing, Uterine Neoplasms

NCT06033001 2025-01-13

Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Temporarily not available

Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT05274204 2023-02-27

Individual Patient Expanded Access to CA102N

Temporarily not available

Gastrointestinal

Colorectal Neoplasms

Clinical Trials

Expanded Access to Telisotuzumab Vedotin

Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies

PANOVA-3CA

Expanded Access of Vigil in Solid Tumors

Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Individual Patient Expanded Access to CA102N